Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |